Professionisti del settore sanitario

Consulta CRT-P

Cardiac Resynchronization Therapy Pacemaker

Consulta Cardiac Resynchronization Pacemaker (CRT-P)

The Medtronic Consulta® CRT-P system is designed specifically for patients who are candidates for cardiac resynchronization therapy and indicated for a bradycardia pacemaker.

How It Works

Consulta® CRT-P combines industry-leading pacing technology, cardiac resynchronization therapy, and Medtronic exclusive features for proactive heart failure management.


Important Safety Information

Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.


Medtronic Exclusives
  Exclusive   Exclusive Exclusive  
OptiVol
Monitoring
5
Pacing
Vectors
Complete
Capture
Management
Leadless
ECG
CareLink
Network
Consulta®
CRT-P
Pacemaker
x x x x x
Espandi tutto

Diagnostics

Heart Failure Diagnostics

Medtronic heart failure diagnostic tools help clinicians identify patients at risk of heart failure hospitalization:1-7

OptiVol® Fluid Status Monitoring uses intrathoracic impedance to indicate fluid status in heart failure patients.

CardioSight Reader helps clinicians quickly identify issues and respond to significant clinical events in heart failure patients.

Medtronic Cardiac Compass Report provides an easy-to-read report, another tool to help guide clinician decisions.


Important Safety Information

Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.


References

1

Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. August 9, 2005; 112(6):841-848.

2

Vollmann D, Nägele H, Schauert P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. August 2007; 28(15):1835-1840.

3

Catanzariti D, Lunati M, Landolina M, et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. PACE. March 2008; 32(3):363-370.

4

Perego GB, Landolina M, Vergara G, et al. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. J Interv Card Electrophysiol. December 2008; 23(3):235-242.

5

Small RS, Wickemeyer W, Germany R, et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. August 2009;15(6):475-481.

6

Abraham WT. Superior performance of intrathoracic impedance-derived fluid index versus daily weight monitoring in heart failure patients. Results of the Fluid Accumulation Status Trial. Late Breaking Clinical Trials. J Card Fail. Vol. 15 No. 9 2009, p 813.

7

Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients with Heart Failure) study. J Am Coll Cardiol. April 27, 2010;55(17):1803-1810.

Pacing Vectors

Ensure CRT

Follow-Up

Specs